Cryoactiv Regenerative Processing Plant

Cryoactiv Regenerative Processing Plant is a specialized biotechnology facility focused on the processing and distribution of regenerative biologics derived from human birth tissues. Operating as the primary manufacturing arm for Amnio Technology, the plant utilizes a proprietary Cryoactiv processing method designed to preserve the structural integrity and biological activity of amniotic and umbilical cord allografts. Their product portfolio, which includes the PalinGen and AmnioAmp lines, is utilized in clinical settings for wound care, orthopedics, and surgical applications to promote tissue repair and reduce inflammation. The facility is FDA-registered and maintains accreditation from the American Association of Tissue Banks (AATB), ensuring high standards of safety and quality. By leveraging advanced cryopreservation and dehydration techniques, the company provides clinicians with versatile biologic solutions for complex regenerative needs.